Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women

Endocrine

Volumn 42, Issue 2, 2012, Pages 423-429

  Moon, Seong Su ^a   Lee, Young Sil ^a   Kim, Sung Woo ^a  

^a Dongguk University College of Medicine   (South Korea)

Author keywords

Bone mineral density; Metabolic syndrome; Nonalcoholic fatty liver disease; Osteoporosis; Postmenopause

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE; BODY MASS; BONE DENSITY; BONE MASS; CONTROLLED STUDY; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LUMBAR SPINE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OSTEOPOROSIS; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; SMOKING; SOUTH KOREA;

EID: 84867399647     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-012-9639-6     Document Type: Article

References (43)

1. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am. J. Med. 94(6), 646-650 (1993)
2. C. Cooper, E.J. Atkinson, S.J. Jacobsen, W.M. O'Fallon, L.J. Melton 3rd, Population-based study of survival after osteoporotic fractures. Am. J. Epidemiol. 137(9), 1001-1005 (1993)
3. M.A. Petit, M.L. Paudel, B.C. Taylor, J.M. Hughes, E.S. Strotmeyer, A.V. Schwartz, J.A. Cauley, J.M. Zmuda, A.R. Hoffman, K.E. Ensrud, Bone mass and strength in older men with type 2 diabetes: the Osteoporotic Fractures in Men Study. J. Bone Miner. Res. 25(2), 285-291 (2010)
4. D. von Muhlen, S. Safii, S.K. Jassal, J. Svartberg, E. Barrett-Connor, Associations between the metabolic syndrome and bone health in older men and women: the Rancho Bernardo Study. Osteoporos. Int. 18(10), 1337-1344 (2007)
5. D.K. Hwang, H.J. Choi, The relationship between low bone mass and metabolic syndrome in Korean women. Osteoporos. Int. 21(3), 425-431 (2010)
6. Kim, K.C., Shin, D.H., Lee, S.Y., Im, J.A., Lee, D.C.: Relation between obesity and bone mineral density and vertebral fractures in Korean postmenopausal women. Yonsei Med J 51(6), 857-863 (2010)
7. Y.K. Jeon, J.G. Lee, S.S. Kim, B.H. Kim, S.J. Kim, Y.K. Kim, I.J. Kim, Association between bone mineral density and metabolic syndrome in pre- and postmenopausal women. Endocr. J. 58(2), 87-93 (2011)
8. M.A. Cornier, D. Dabelea, T.L. Hernandez, R.C. Lindstrom, A.J. Steig, N.R. Stob, R.E. Van Pelt, H. Wang, R.H. Eckel, The metabolic syndrome. Endocr. Rev. 29(7), 777-822 (2008)
9. G.A. Bray, T. Bellanger, Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine 29(1), 109-117 (2006)
10. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 106(25), 3143-3421 (2002)
11. A.I. Shulman, D.J. Mangelsdorf, Retinoid x receptor heterodimers in the metabolic syndrome. N. Engl. J. Med. 353(6), 604-615 (2005)
12. E. Scorletti, P.C. Calder, C.D. Byrne, Non-alcoholic fatty liver disease and cardiovascular risk: metabolic aspects and novel treatments. Endocrine 40(3), 332-343 (2011)
13. S.M. Grundy, Metabolic complications of obesity. Endocrine 13(2), 155-165 (2000)
14. G. Targher, L. Bertolini, R. Padovani, S. Rodella, R. Tessari, L. Zenari, C. Day, G. Arcaro, Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 30(5), 1212-1218 (2007)
15. S. Bellentani, G. Saccoccio, F. Masutti, L.S. Croce, G. Brandi, F. Sasso, G. Cristanini, C. Tiribelli, Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann. Intern. Med. 132(2), 112-117 (2000)
16. J.R. Lewis, S.R. Mohanty, Nonalcoholic fatty liver disease: a review and update. Dig. Dis. Sci. 55(3), 560-578 (2010)
17. M. Lazo, J.M. Clark, The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin. Liver Dis. 28(4), 339-350 (2008)
18. C. Loguercio, T. De Simone, M.V. D'Auria, I. de Sio, A. Federico, C. Tuccillo, A.M. Abbatecola, C. Del Vecchio Blanco, Nonalcoholic fatty liver disease: a multicentre clinical study by the Italian Association for the Study of the Liver. Dig. Liver Dis. 36(6), 398-405 (2004). doi:10.1016/j.dld.2004.01. 022
19. C. Loguercio, V. De Girolamo, I. de Sio, C. Tuccillo, A. Ascione, F. Baldi, G. Budillon, L. Cimino, A. Di Carlo, M.P. Di Marino, F. Morisco, F. Picciotto, L. Terracciano, R. Vecchione, V. Verde, C. Del Vecchio Blanco, Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects. J. Hepatol. 35(5), 568-574 (2001)
20. World Health Organization. The Asia-Pacific perspective: redefining obesity and its treatment.Health Communication, Sydney (2000)
21. A.J. Sanyal, AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 123(5), 1705-1725 (2002)
22. D. Joy, V.R. Thava, B.B. Scott, Diagnosis of fatty liver disease: Is biopsy necessary? Eur. J. Gastroenterol. Hepatol. 15(5), 539-543 (2003)
23. S.H. Park, W.K. Jeon, S.H. Kim, H.J. Kim, D.I. Park, Y.K. Cho, I.K. Sung, C.I. Sohn, D.K. Keum, B.I. Kim, Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J. Gastroenterol. Hepatol. 21(1 Pt 1), 138-143 (2006)
24. J.M. Clark, F.L. Brancati, A.M. Diehl, Nonalcoholic fatty liver disease. Gastroenterology 122(6), 1649-1657 (2002)
25. A. Suzuki, M.F. Abdelmalek, Nonalcoholic fatty liver disease in women. Womens Health (Lond. Engl.) 5(2), 191-203 (2009)
26. Y.H. Hsu, S.A. Venners, H.A. Terwedow, Y. Feng, T. Niu, Z. Li, N. Laird, J.D. Brain, S.R. Cummings, M.L. Bouxsein, C.J. Rosen, X. Xu, Relation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women. Am. J. Clin. Nutr. 83(1), 146-154 (2006)
27. L.J. Zhao, Y.J. Liu, P.Y. Liu, J. Hamilton, R.R. Recker, H.W. Deng, Relationship of obesity with osteoporosis. J. Clin. Endocrinol. Metab. 92(5), 1640-1646 (2007). doi:10.1210/jc.2006-0572
28. W.Y. Lee, J.S. Park, S.Y. Noh, E.J. Rhee, K.C. Sung, B.S. Kim, J.H. Kang, S.W. Kim, M.H. Lee, J.R. Park, C-reactive protein concentrations are related to insulin resistance and metabolic syndrome as defined by the ATP III report. Int. J. Cardiol. 97(1), 101-106 (2004)
29. D.H. Jones, Y.Y. Kong, J.M. Penninger, Role of RANKL and RANK in bone loss and arthritis. Ann. Rheum. Dis. 61(Suppl 2), ii32-39 (2002)
30. L.C. Hofbauer, M. Schoppet, Clinical implications of the osteoprotegerin/ RANKL/RANK system for bone and vascular diseases. JAMA 292(4), 490-495 (2004)
31. M. Krawczyk, L. Bonfrate, P. Portincasa, Nonalcoholic fatty liver disease. Best Pract. Res. Clin. Gastroenterol. 24(5), 695-708 (2010)
32. P. Trayhurn, I.S. Wood, Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem. Soc. Trans. 33(Pt 5), 1078-1081 (2005)
33. P. Trayhurn, Adipose tissue in obesity-an inflammatory issue. Endocrinology 146(3), 1003-1005 (2005)
34. T. Diamond, D. Stiel, M. Lunzer, M. Wilkinson, J. Roche, S. Posen, Osteoporosis and skeletal fractures in chronic liver disease. Gut 31(1), 82-87 (1990)
35. P. Angulo, T.M. Therneau, A. Jorgensen, C.K. DeSotel, K.S. Egan, E.R. Dickson, J.E. Hay, K.D. Lindor, Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression. J. Hepatol. 29(5), 729-735 (1998)
36. S.P. Pereira, G.P. Bray, P.I. Pitt, F. Li, C. Moniz, R. Williams, Non-invasive assessment of bone density in primary biliary cirrhosis. Eur. J. Gastroenterol. Hepatol. 11(3), 323-328 (1999)
37. J. Newton, R. Francis, M. Prince, O. James, M. Bassendine, D. Rawlings, D. Jones, Osteoporosis in primary biliary cirrhosis revisited. Gut 49(2), 282-287 (2001)
38. G.W. McCaughan, R.B. Feller, Osteoporosis in chronic liver disease: pathogenesis, risk factors, and management. Dig. Dis. 12(4), 223-231 (1994)
39. C.H. Janes, E.R. Dickson, R. Okazaki, S. Bonde, A.F. McDonagh, B.L. Riggs, Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice. J Clin Invest 95(6), 2581-2586 (1995)
40. F.J. Gallego-Rojo, J.L. Gonzalez-Calvin, M. Munoz-Torres, J.L. Mundi, R. Fernandez-Perez, D. Rodrigo-Moreno, Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis. Hepatology 28(3), 695-699 (1998)
41. J.A. Cuthbert, C.Y. Pak, J.E. Zerwekh, K.D. Glass, B. Combes, Bone disease in primary biliary cirrhosis: increased bone resorption and turnover in the absence of osteoporosis or osteomalacia. Hepatology 4(1), 1-8 (1984)
42. G. Mazziotti, M. Gola, A. Bianchi, T. Porcelli, A. Giampietro, V. Cimino, M. Doga, C. Gazzaruso, L. De Marinis, A. Giustina, Influence of diabetes mellitus on vertebral fractures in men with acromegaly. Endocrine 40(1), 102-108 (2011)
43. G. Mazziotti, J. Bilezikian, E. Canalis, D. Cocchi, A. Giustina, New understanding and treatments for osteoporosis. Endocrine 41(1), 58-69 (2012)